Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis

Over the past two decades, transcatheter aortic valve implantation (TAVI) for the treatment of degenerative severe aortic valve stenosis has become a well-established therapeutic option with increasing scientific evidence. TAVI procedure indications are not determined purely by the risk of cardiac s...

Full description

Saved in:
Bibliographic Details
Main Authors: Zalán Gulyás, Gábor Kerecsen, Emese Tóth-Zsámboki, Zsófia Horváth, Róbert Gábor Kiss, Zoltán Gábor Duray
Format: Article
Language:English
Published: Promenade Kft 2024-10-01
Series:Cardiologia Hungarica
Subjects:
Online Access:https://cardiologia.hungarica.eu/archive/2024-issues/2024-5-contents/expanding-indications-of-transcatheter-aortic-valve-implantation-and-cornerstones-of-the-lifetime-management-of-patients-with-severe-aortic-stenosis?article=open
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846169730036006912
author Zalán Gulyás
Gábor Kerecsen
Emese Tóth-Zsámboki
Zsófia Horváth
Róbert Gábor Kiss
Zoltán Gábor Duray
author_facet Zalán Gulyás
Gábor Kerecsen
Emese Tóth-Zsámboki
Zsófia Horváth
Róbert Gábor Kiss
Zoltán Gábor Duray
author_sort Zalán Gulyás
collection DOAJ
description Over the past two decades, transcatheter aortic valve implantation (TAVI) for the treatment of degenerative severe aortic valve stenosis has become a well-established therapeutic option with increasing scientific evidence. TAVI procedure indications are not determined purely by the risk of cardiac surgery and progressively, more and more consider patient’s life expectancy. Current guidelines leave "grey zones" alongside the first class recommendations for TAVI and surgical aortic valve replacement (SAVR), providing an opportunity to make optimal decision between different therapies, taking into account advantages and disadvantages of both interventions, patient's interests and local circumstances. Since patients treated with TAVI have come to be younger, several factors and different characteristics of the intervention must be considered individually (lifetime management). In addition to intraventricular conduction disturbances, pacemaker implantation, paravalvular leak, valve durability, the feasibility of percutaneous coronary interventions after TAVI and potential aortic valve reinterventions are the most important issues. The choice of the first intervention – whether it is TAVI or SAVR – is crucial, as it can determine the patient's quality of life, valve durability and the feasibility of subsequent invasive procedures.
format Article
id doaj-art-41ab4f4793be4c62a540161b388f021e
institution Kabale University
issn 0133-5596
1588-0230
language English
publishDate 2024-10-01
publisher Promenade Kft
record_format Article
series Cardiologia Hungarica
spelling doaj-art-41ab4f4793be4c62a540161b388f021e2024-11-12T09:06:22ZengPromenade KftCardiologia Hungarica0133-55961588-02302024-10-0154536937710.26430/CHUNGARICA.2024.54.5.369Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosisZalán Gulyás0Gábor Kerecsen1Emese Tóth-Zsámboki2Zsófia Horváth3Róbert Gábor Kiss4Zoltán Gábor Duray5Észak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestÉszak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestÉszak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestÉszak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestÉszak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestÉszak-pesti Centrumkórház – Honvédkórház, Kardiológia, BudapestOver the past two decades, transcatheter aortic valve implantation (TAVI) for the treatment of degenerative severe aortic valve stenosis has become a well-established therapeutic option with increasing scientific evidence. TAVI procedure indications are not determined purely by the risk of cardiac surgery and progressively, more and more consider patient’s life expectancy. Current guidelines leave "grey zones" alongside the first class recommendations for TAVI and surgical aortic valve replacement (SAVR), providing an opportunity to make optimal decision between different therapies, taking into account advantages and disadvantages of both interventions, patient's interests and local circumstances. Since patients treated with TAVI have come to be younger, several factors and different characteristics of the intervention must be considered individually (lifetime management). In addition to intraventricular conduction disturbances, pacemaker implantation, paravalvular leak, valve durability, the feasibility of percutaneous coronary interventions after TAVI and potential aortic valve reinterventions are the most important issues. The choice of the first intervention – whether it is TAVI or SAVR – is crucial, as it can determine the patient's quality of life, valve durability and the feasibility of subsequent invasive procedures.https://cardiologia.hungarica.eu/archive/2024-issues/2024-5-contents/expanding-indications-of-transcatheter-aortic-valve-implantation-and-cornerstones-of-the-lifetime-management-of-patients-with-severe-aortic-stenosis?article=openaortic valve stenosistranscatheter aortic valve implantationtavi durabilityaortic valve reinterventionlifetime management
spellingShingle Zalán Gulyás
Gábor Kerecsen
Emese Tóth-Zsámboki
Zsófia Horváth
Róbert Gábor Kiss
Zoltán Gábor Duray
Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
Cardiologia Hungarica
aortic valve stenosis
transcatheter aortic valve implantation
tavi durability
aortic valve reintervention
lifetime management
title Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
title_full Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
title_fullStr Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
title_full_unstemmed Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
title_short Expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
title_sort expanding indications of transcatheter aortic valve implantation and cornerstones of the lifetime management of patients with severe aortic stenosis
topic aortic valve stenosis
transcatheter aortic valve implantation
tavi durability
aortic valve reintervention
lifetime management
url https://cardiologia.hungarica.eu/archive/2024-issues/2024-5-contents/expanding-indications-of-transcatheter-aortic-valve-implantation-and-cornerstones-of-the-lifetime-management-of-patients-with-severe-aortic-stenosis?article=open
work_keys_str_mv AT zalangulyas expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis
AT gaborkerecsen expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis
AT emesetothzsamboki expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis
AT zsofiahorvath expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis
AT robertgaborkiss expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis
AT zoltangaborduray expandingindicationsoftranscatheteraorticvalveimplantationandcornerstonesofthelifetimemanagementofpatientswithsevereaorticstenosis